Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CCXI ChemoCentryx > Detailed Quotes

CCXI ChemoCentryx

51.850
+0.030+0.06%
Trading Session 10/04 09:53 ET
High
51.890
Open
51.840
Turnover
6.37M
Low
51.800
Pre Close
51.820
Volume
122.78K
Market Cap
3.70B
P/E(TTM)
Loss
52wk High
51.890
Shares
71.36M
P/E(Static)
Loss
52wk Low
14.950
Float Cap
2.99B
Bid/Ask %
55.56%
Historical High
70.290
Shs Float
57.71M
Volume Ratio
1.52
Historical Low
1.921
Dividend TTM
--
Div Yield TTM
--
P/B
15.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.21%
Amplitude
0.17%
Avg Price
51.845
Lot Size
1
Float Cap
2.99B
Bid/Ask %
55.56%
Historical High
70.290
Shs Float
57.71M
Volume Ratio
1.52
Historical Low
1.921
Dividend TTM
--
P/B
15.64
Dividend LFY
--
Turnover Ratio
0.21%
Amplitude
0.17%
Avg Price
51.845
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.
CEO: Dr. Thomas J. Schall, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...